XML 39 R25.htm IDEA: XBRL DOCUMENT v3.23.1
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Cash generated from operations $ 1,900,000  
Net loss 2,700,000  
Working capital 448,000  
Accumulated Deficit 9,100,000  
Cash 61,000 $ 1,300,000
Depreciation and amortization expense 25,643 9,852
Impairment charges on goodwill 0 0
Reduction of accrued allowances 26,700 8,000
Research and Development Expense 203,751 308,823
Selling Expense 50,150 1,237
Stock-based compensation expense $ 7,844 $ 15,619
Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive shares 608,288 888,288
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive shares 199,733 199,733